Clinical study for the treatment of atherosclerotic angiopathy with traditional Chinese Medicine

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027117

Enrollment

Unknown

Registered

2019-11-01

Start date

2019-11-05

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis

Interventions

1:Oral TCM

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. CTA showing lower extremity vascular stenosis,Stenosis > 40%; 2. Aged 30 to 70 years, regardless of gender; 3. Those who can adhere to long-term medication; 4. Patients who volunteer to participate in the study, informed consent, and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. There are serious diseases such as heart, liver, kidney, hematopoietic system, endocrine system, respiratory system, etc., 2. Pregnant or lactating women; 3. Allergic constitution; 4. Other diseases or psychosis that the investigator believes may limit efficacy evaluation or patient follow-up; 5. Patients who have participated in other drug clinical trials in the past 4 weeks.

Design outcomes

Primary

Measure	Time frame
degree of arterial stenosis;	—

Secondary

Measure	Time frame
Color Doppler ultrasound;	—

Countries

China

Contacts

Public ContactLiu Feng

Hebei Petro China Central Hospital

liufeng3021@163.com+86 13810604805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026